Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_005159.5(ACTC1):c.524_525insC (p.Ala176fs)	ACTC1|GJD2-DT	A176fs	Wolff-Parkinson-White pattern	Likely pathogenic(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487625	15	35084700 - 35084701	15	34792499 - 34792500	487625	480715	rs1555418832	NC_000015.10:34792499::G
ATP13A2, 22-BP DUP	ATP13A2		Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Aug 26, 2011)	no assertion criteria provided	VCV000001220					1220	16259		
NM_000077.5(CDKN2A):c.339_340delinsCT (p.Pro114Ser)	CDKN2A	P114S, A128L, P63S	Cutaneous malignant melanoma 2|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 15, 2014)	criteria provided, single submitter	VCV000009424	9	21971018 - 21971019	9	21971019 - 21971020	9424	24463	rs387906410	NC_000009.12:21971018:GC:AG
NC_000009.11:g.(?_34458994)_(35072710_?)dup	CNTFR|GALT|IL11RA|CCL19|CCL21|VCP|SIGMAR1|CCL27|DCTN3|PHF24|DNAJB5|DNAI1|ARID3C|RPP25L|C9orf131|FAM205A|ENHO		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Distal spinal muscular atrophy, autosomal recessive 2|Amyotrophic lateral sclerosis 16, juvenile	Uncertain significance(Last reviewed: Jul 29, 2020)	criteria provided, single submitter	VCV001042271	9	34458994 - 35072710			1042271	1022311		
NM_032409.3(PINK1):c.*673_*675dup	DDOST|PINK1|PINK1-AS		Parkinson Disease, Recessive|Congenital disorder of glycosylation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295029	1	20977854 - 20977855	1	20651361 - 20651362	295029	278557	rs3077908	NC_000001.11:20651361:TTCTT:TTCTTCTT
NM_032409.3(PINK1):c.*573_*576dup	DDOST|PINK1|PINK1-AS		Parkinson Disease, Recessive|Congenital disorder of glycosylation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295026	1	20977754 - 20977755	1	20651261 - 20651262	295026	279815	rs143763511	NC_000001.11:20651261:CTGACT:CTGACTGACT
NC_000001.11:g.(?_65388326)_(65413035_?)dup	DNAJC6		Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000830927	1	65854009 - 65878718			830927	818991		
DRD4, 120-BP INS	DRD4		Attention deficit-hyperactivity disorder, susceptibility to	risk factor(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016769					16769	31808		
NM_012179.4(FBXO7):c.1271_1272delinsAT (p.Phe424Tyr)	FBXO7	F310Y, F345Y, F424Y	Parkinson disease 15	Benign(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV000704113	22	32894219 - 32894220	22	32498232 - 32498233	704113	694717	rs1601520476	NC_000022.11:32498231:TC:AT
NM_012179.4(FBXO7):c.1206_1207dup (p.Arg403fs)	FBXO7	R289fs, R324fs, R403fs	Parkinson disease 15	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000641981	22	32894152 - 32894153	22	32498165 - 32498166	641981	649457	rs749019340	NC_000022.11:32498165:AAA:AAAAA
NM_000157.4(GBA):c.84dup (p.Leu29fs)	GBA	L29fs	Gaucher disease|Hereditary late onset Parkinson disease|Gaucher disease type I|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|not provided	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004302	1	155210451 - 155210452	1	155240660 - 155240661	4302	19341	rs387906315	NC_000001.11:155240660:C:CC
NM_001103146.3(GIGYF2):c.3629_3630insGC (p.Gln1211fs)	GIGYF2	Q1211fs, Q1205fs, Q1232fs	not provided|not specified|Parkinson disease 11	Benign/Likely benign(Last reviewed: Jun 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000402899	2	233712226 - 233712227	2	232847515 - 232847516	402899	389487	rs371622656	NC_000002.12:232847515:C:CGC
NM_032620.4(GTPBP3):c.32_33delinsGTG (p.Gln11fs)	GTPBP3	Q11fs	Combined oxidative phosphorylation deficiency 23	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000180619	19	17448452 - 17448453	19	17337643 - 17337644	180619	178785	rs886037736	NC_000019.10:17337642:AA:GTG
NC_000007.14:g.(?_26200562)_(26200587_?)dup	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000830531	7	26240182 - 26240207			830531	819866		
NM_002137.4(HNRNPA2B1):c.842-11dup	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not provided	Benign(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000750886	7	26232998 - 26232999	7	26193378 - 26193379	750886	775372	rs1465279377	NC_000007.14:26193378:AAAAAA:AAAAAAA
NM_198578.4(LRRK2):c.2701_2702delinsCT (p.Ser901Leu)	LRRK2	S901L	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000465215	12	40687358 - 40687359	12	40293556 - 40293557	465215	462432	rs1555184069	NC_000012.12:40293555:TC:CT
NM_198578.4(LRRK2):c.*934_*936dup	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308665	12	40762492 - 40762493	12	40368690 - 40368691	308665	330877	rs367772598	NC_000012.12:40368690:TTTTTTTTTTT:TTTTTTTTTTTTTT
NM_198578.4(LRRK2):c.*935_*936dup	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308664	12	40762492 - 40762493	12	40368690 - 40368691	308664	317038	rs367772598	NC_000012.12:40368690:TTTTTTTTTTT:TTTTTTTTTTTTT
NM_198578.4(LRRK2):c.*936dup	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308663	12	40762492 - 40762493	12	40368690 - 40368691	308663	332395	rs367772598	NC_000012.12:40368690:TTTTTTTTTTT:TTTTTTTTTTTT
NM_198578.4(LRRK2):c.6844-14_6844-13insA	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Feb 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000308645	12	40753048 - 40753049	12	40359246 - 40359247	308645	332380	rs150964683	NC_000012.12:40359246::A
NM_198578.4(LRRK2):c.6281-3dup	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308641	12	40742204 - 40742205	12	40348402 - 40348403	308641	332364	rs780258764	NC_000012.12:40348402:TTTT:TTTTT
NM_198578.4(LRRK2):c.2689+20dup	LRRK2		not provided|Parkinson disease 8, autosomal dominant|not specified	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308619	12	40681352 - 40681353	12	40287550 - 40287551	308619	332330	rs66810434	NC_000012.12:40287550:AAAAAAAAA:AAAAAAAAAA
NM_198578.4(LRRK2):c.2501-9dup	LRRK2		not provided|Parkinson disease 8, autosomal dominant|not specified	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000308617	12	40681142 - 40681143	12	40287340 - 40287341	308617	330850	rs36220740	NC_000012.12:40287340:TT:TTT
NM_198578.4(LRRK2):c.7186_7187dup (p.Val2396_Met2397insTer)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039237	12	40758647 - 40758648	12	40364845 - 40364846	39237	47843	rs281865056	NC_000012.12:40364845:GT:GTGT
NM_005460.4(SNCAIP):c.*574dup	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350511	5	121799761 - 121799762	5	122464066 - 122464067	350511	300497	rs574096351	NC_000005.10:122464066:GGGG:GGGGG
NM_006186.4(NR4A2):c.881dup (p.Asn294fs)	NR4A2	N231fs, N294fs	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000930579	2	157185028 - 157185029	2	156328516 - 156328517	930579	918675		NC_000002.12:156328516:TTTTTTT:TTTTTTTT
NM_007262.5(PARK7):c.90+1dup	PARK7		Parkinson disease 7	Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000804432	1	8022932 - 8022933	1	7962872 - 7962873	804432	792720	rs1578089802	NC_000001.11:7962872:GGGG:GGGGG
NM_007262.5(PARK7):c.252+8dup	PARK7		Parkinson disease 7|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000675657	1	8029466 - 8029467	1	7969406 - 7969407	675657	658097	rs781094807	NC_000001.11:7969406:AAAAAA:AAAAAAA
NC_000001.10:g.(?_8022836)_(8031035_?)dup	PARK7		Parkinson disease 7	Uncertain significance(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000650723	1	8022836 - 8031035	1	7962776 - 7970975	650723	650547		
NM_007262.5(PARK7):c.105dup (p.Ala36fs)	PARK7	A36fs	Parkinson disease 7	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000573287	1	8025396 - 8025397	1	7965336 - 7965337	573287	557376	rs781600849	NC_000001.11:7965336:TT:TTT
NM_007262.4(PARK7):c.[-24+75_-24+92dup;487G>A]	PARK7	E163K	Parkinson disease 7	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000446717	1|1	8021910 - 8021911	1|1	7961850 - 7961851	446717	75266|22107	rs200968609|rs74315354	NC_000001.11:7961850:GTGCTGGACGGTGTCCCTGTGCTGGACGGTGTCCC:GTGCTGGACGGTGTCCCTGTGCTGGACGGTGTCCCTGTGCTGGACGGTGTCCC|NC_000001.11:7984970:G:A
NM_032409.3(PINK1):c.1570_1573dup (p.Asp525fs)	PINK1|PINK1-AS	D525fs	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000002409	1	20977005 - 20977006	1	20650512 - 20650513	2409	17448	rs730880302	NC_000001.11:20650512:AGTTAG:AGTTAGTTAG
NM_005216.5(DDOST):c.*375_*376dup	PINK1-AS|DDOST|PINK1		Parkinson Disease, Recessive|Congenital disorder of glycosylation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295050	1	20978495 - 20978496	1	20652002 - 20652003	295050	279979	rs200971370	NC_000001.11:20652002:TTTT:TTTTTT
NM_001018111.3(PODXL):c.89_90insGTCGCCCC (p.Gln32fs)	PODXL	Q32fs	not provided|Parkinson disease 2	Likely pathogenic(Last reviewed: Dec 12, 2015)	criteria provided, single submitter	VCV000218942	7	131241029 - 131241030	7	131556270 - 131556271	218942	215779	rs1554391082	NC_000007.14:131556270:GG:GGGGCGACGG
NM_016203.4(PRKAG2):c.*1021_*1022delinsGT	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359325	7	151253265 - 151253266	7	151556179 - 151556180	359325	302210	rs886062094	NC_000007.14:151556178:CA:AC
NM_016203.4(PRKAG2):c.*1029dup	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359324	7	151253257 - 151253258	7	151556171 - 151556172	359324	302207	rs1554444891	NC_000007.14:151556171:CCC:CCCC
NM_016203.4(PRKAG2):c.*1040dup	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359322	7	151253246 - 151253247	7	151556160 - 151556161	359322	302204	rs56898021	NC_000007.14:151556160:AAAAAAAAAAA:AAAAAAAAAAAA
NM_016203.4(PRKAG2):c.*1041dup	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359321	7	151253245 - 151253246	7	151556159 - 151556160	359321	302201	rs886062093	NC_000007.14:151556159:G:GG
NM_016203.4(PRKAG2):c.1050_1051insTTA (p.Glu351_Leu352insLeu)	PRKAG2		Familial hypertrophic cardiomyopathy 6	Pathogenic(Last reviewed: May 15, 2001)	no assertion criteria provided	VCV000006848	7	151269750 - 151269751	7	151572664 - 151572665	6848	21887	rs587776643	NC_000007.14:151572664::TAA
NC_000006.12:g.(?_162262525)_(162275409_?)dup	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000830820	6	162683557 - 162696441			830820	819680		
NC_000006.11:g.(?_162622143)_(163148721_?)dup	PRKN|PACRG		not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000662856	6	162622143 - 163148721	6	162201111 - 162727689	662856	651583		
NC_000006.11:g.(?_162206794)_(162206950_?)dup	PRKN		not provided	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000657369	6	162206794 - 162206950	6	161785762 - 161785918	657369	651489		
NC_000006.11:g.(?_162622153)_(162683807_?)dup	PRKN		not provided	Uncertain significance(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000651253	6	162622153 - 162683807	6	162201121 - 162262775	651253	651586		
NC_000006.11:g.(?_162206784)_(162206960_?)dup	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000639364	6	162206784 - 162206960	6	161785752 - 161785928	639364	651540		
NC_000006.11:g.(?_162394314)_(162475226_?)dup	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000583917	6	162394314 - 162475226	6	161973282 - 162054194	583917	560506		
NC_000006.11:g.(?_162683537)_(162683817_?)dup	PRKN		Parkinson disease 2	Likely pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000583519	6	162683537 - 162683817	6	162262505 - 162262785	583519	560508		
NC_000006.11:g.(?_161969866)_(161970055_?)dup	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000583484	6	161969866 - 161970055	6	161548834 - 161549023	583484	563258		
NC_000006.11:g.(?_162683537)_(162864525_?)dup	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000583436	6	162683537 - 162864525	6	162262505 - 162443493	583436	563260		
NC_000006.11:g.(?_162864322)_(162864525_?)dup	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000468582	6	162864322 - 162864525	6	162443290 - 162443493	468582	455272		
NC_000006.11:g.(?_161768590)_(162475206_?)dup	PRKN|LOC105378098|LOC121132714		Parkinson disease 2	Uncertain significance(Last reviewed: Aug 5, 2016)	criteria provided, single submitter	VCV000417462	6	161768590 - 162475206	6	161347558 - 162054174	417462	394996		
NC_000006.11:g.(?_162622163)_(162622284_?)dup	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000417461	6	162622163 - 162622284	6	162201131 - 162201252	417461	394998		
NC_000004.11:g.(?_90647315)_(90756828_?)dup	SNCA		Lewy body dementia|Parkinson disease 1	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000639372	4	90647315 - 90756828	4	89726164 - 89835677	639372	651126		
NC_000004.11:g.(?_90647315)_(90756838_?)dup	SNCA		Parkinson disease 1|Lewy body dementia	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, single submitter	VCV000531846	4	90647315 - 90756838	4	89726164 - 89835687	531846	519673		
NM_000345.4(SNCA):c.*1291_*1292insTTTCT	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350083	4	90646487 - 90646488	4	89725336 - 89725337	350083	299903	rs1553905630	NC_000004.12:89725336:AGA:AGAAAAGA
NM_000345.4(SNCA):c.*1292_*1296dup	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350082	4	90646482 - 90646483	4	89725331 - 89725332	350082	294640	rs886059721	NC_000004.12:89725331:AAAAGA:AAAAGAAAAGA
NM_000345.4(SNCA):c.*1291_*1292insTTTTT	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350081	4	90646487 - 90646488	4	89725336 - 89725337	350081	296179	rs886059720	NC_000004.12:89725336:A:AAAAAA
NM_000345.4(SNCA):c.*1291_*1292insTTT	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350080	4	90646487 - 90646488	4	89725336 - 89725337	350080	299956	rs886059720	NC_000004.12:89725336:A:AAAA
NM_000345.4(SNCA):c.*1308_*1309dup	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350079	4	90646469 - 90646470	4	89725318 - 89725319	350079	299953	rs397994464	NC_000004.12:89725318:AAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAA
NM_000345.4(SNCA):c.*1305_*1309dup	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350078	4	90646469 - 90646470	4	89725318 - 89725319	350078	294637	rs397994464	NC_000004.12:89725318:AAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAA
NM_000345.4(SNCA):c.*1306_*1309dup	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350077	4	90646469 - 90646470	4	89725318 - 89725319	350077	294636	rs397994464	NC_000004.12:89725318:AAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAA
NM_000345.4(SNCA):c.*1306_*1310dup	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350075	4	90646468 - 90646469	4	89725317 - 89725318	350075	299890	rs1553905608	NC_000004.12:89725317:TAAAA:TAAAATAAAA
NM_000345.4(SNCA):c.*1308_*1310dup	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350074	4	90646468 - 90646469	4	89725317 - 89725318	350074	294634	rs1553905607	NC_000004.12:89725317:TAA:TAATAA
NM_000345.4(SNCA):c.*1310_*1311insTTTTT	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350073	4	90646468 - 90646469	4	89725317 - 89725318	350073	294633	rs886059718	NC_000004.12:89725317::AAAAA
NM_000345.4(SNCA):c.*1310_*1311insTTT	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350072	4	90646468 - 90646469	4	89725317 - 89725318	350072	299881	rs886059718	NC_000004.12:89725317::AAA
NM_000345.4(SNCA):c.*1307_*1311dup	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350070	4	90646467 - 90646468	4	89725316 - 89725317	350070	299888	rs886059716	NC_000004.12:89725316:GTAAA:GTAAAGTAAA
SNCA, DUPLICATION	SNCA		Parkinson disease 1|Lewy body dementia	Pathogenic(Last reviewed: Oct 14, 2008)	no assertion criteria provided	VCV000014011					14011	29050		
NM_203446.3(SYNJ1):c.1279_1280dup (p.Met428fs)	SYNJ1	M428fs, M467fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001075587	21	34053878 - 34053879	21	32681568 - 32681569	1075587	1064884		NC_000021.9:32681568:GA:GAGA
NM_203446.3(SYNJ1):c.1093dup (p.Tyr365fs)	SYNJ1	Y365fs, Y404fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Jun 29, 2020)	criteria provided, single submitter	VCV001074545	21	34058082 - 34058083	21	32685772 - 32685773	1074545	1064885		NC_000021.9:32685772:AAAAAAA:AAAAAAAA
NM_203446.3(SYNJ1):c.3438dup (p.Ala1147fs)	SYNJ1	A1147fs, A1186fs	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001070684	21	34015759 - 34015760	21	32643449 - 32643450	1070684	1064883		NC_000021.9:32643449:T:TT
NM_003895.3(SYNJ1):c.12_13dup (p.Trp5fs)	SYNJ1	W5fs	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001069960	21	34100338 - 34100339	21	32728027 - 32728028	1069960	1064886		NC_000021.9:32728027:AT:ATAT
NC_000021.8:g.(?_32439271)_(37133458_?)dup	SYNJ1|URB1|KCNE2|OLIG2|CRYZL1|IFNGR2|IL10RB|ATP5PO|TMEM50B|KCNE1|RUNX1|RCAN1|GART|IFNAR1|IFNAR2|ITSN1|SLC5A3|SOD1|SON|TIAM1|DONSON|HUNK|SMIM11A|MIS18A|CLIC6|DNAJC28|C21orf62|MRAP|CFAP298|SCAF4|EVA1C|MRPS6|PAXBP1|OLIG1|TCP10L		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001035906	21	32439271 - 37133458			1035906	1022419		
NM_203446.3(SYNJ1):c.-56_-55delinsAT	SYNJ1	C21Y	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV001016364	21	34100289 - 34100290	21	32727978 - 32727979	1016364	1014313		NC_000021.9:32727977:GC:AT
NM_203446.3(SYNJ1):c.*227_*244dup	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV001013690	21	34003870 - 34003871	21	32631560 - 32631561	1013690	1014284		NC_000021.9:32631560:GGGATTGACTCCGAGCTGG:GGGATTGACTCCGAGCTGGGGATTGACTCCGAGCTGG
NM_203446.3(SYNJ1):c.3145_3147dup (p.Ser1049dup)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 25, 2020)	criteria provided, single submitter	VCV000950573	21	34018802 - 34018803	21	32646492 - 32646493	950573	929294		NC_000021.9:32646492:ACTA:ACTACTA
NM_203446.3(SYNJ1):c.-64_-53dup	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000943080	21	34100286 - 34100287	21	32727975 - 32727976	943080	939083		NC_000021.9:32727975:CCGCAGCCGCCGCC:CCGCAGCCGCCGCCGCAGCCGCCGCC
NM_203446.3(SYNJ1):c.*186_*187insATTACT	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000846293	21	34003928 - 34003929	21	32631618 - 32631619	846293	848678		NC_000021.9:32631618:A:AGTAATA
NC_000021.9:g.(?_32601843)_(32634904_?)dup	SYNJ1|CFAP298		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000833199	21	33974153 - 34007214			833199	821361		
NC_000021.8:g.(?_34000069)_(34101351_?)dup	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000832807	21	34000069 - 34101351			832807	821352		
NM_203446.3(SYNJ1):c.2541_2542delinsTT (p.His848Tyr)	SYNJ1	H848Y, H887Y, H843Y	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000760171	21	34029350 - 34029351	21	32657040 - 32657041	760171	773286	rs1601309236	NC_000021.9:32657039:GC:AA
NM_203446.3(SYNJ1):c.*186_*187insAATACT	SYNJ1		not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not specified	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000586762	21	34003928 - 34003929	21	32631618 - 32631619	586762	577888	rs57257560	NC_000021.9:32631618:A:AGTATTA
NC_000021.8:g.(?_33974153)_(34074377_?)dup	SYNJ1|CFAP298|CFAP298-TCP10L		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 14, 2018)	criteria provided, single submitter	VCV000584218	21	33974153 - 34074377	21	32601843 - 32702067	584218	573717		
NM_203446.3(SYNJ1):c.706-15dup	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Benign(Last reviewed: Nov 21, 2020)	criteria provided, single submitter	VCV000544582	21	34066627 - 34066628	21	32694317 - 32694318	544582	533791	rs202044634	NC_000021.9:32694317:AAAAAAAAA:AAAAAAAAAA
NM_203446.3(SYNJ1):c.*186_*187insAATAC	SYNJ1	L1320fs, L1406fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Benign(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000544576	21	34003928 - 34003929	21	32631618 - 32631619	544576	533787	rs869265580	NC_000021.9:32631618::GTATT
NM_203446.3(SYNJ1):c.3829dup (p.Gln1277fs)	SYNJ1	Q1230fs, Q1316fs, Q1261fs, Q1277fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000544563	21	34011303 - 34011304	21	32638993 - 32638994	544563	534354	rs1555888341	NC_000021.9:32638993:GGGGG:GGGGGG
NM_203446.3(SYNJ1):c.1933_1934delinsAG (p.Gln645Arg)	SYNJ1	Q645R, Q640R, Q684R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000478332	21	34038761 - 34038762	21	32666451 - 32666452	478332	471120	rs1555896707	NC_000021.9:32666450:TG:CT
NM_007126.5(VCP):c.1696-5dup	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV001149313	9	35059802 - 35059803	9	35059805 - 35059806	1149313	1140512		NC_000009.12:35059805:A:AA
NM_007126.5(VCP):c.446-4_446-3delinsAT	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000842949	9	35065381 - 35065382	9	35065384 - 35065385	842949	851337		NC_000009.12:35065383:GC:AT
NM_007126.5(VCP):c.1082-18_1082-8dup	VCP		not specified|Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000260119	9	35061693 - 35061694	9	35061696 - 35061697	260119	253530	rs11272867	NC_000009.12:35061696:ACAGTACACAAACA:ACAGTACACAAACAGTACACAAACA
NM_020821.3(VPS13C):c.802_805dup (p.Arg269fs)	VPS13C	R269fs, R226fs	Parkinson disease 23, autosomal recessive early-onset	Pathogenic(Last reviewed: Dec 20, 2019)	no assertion criteria provided	VCV000224604	15	62305257 - 62305258	15	62013058 - 62013059	224604	226382	rs869320761	NC_000015.10:62013058:TCTG:TCTGTCTG
NM_020821.3(VPS13C):c.806_807insCAGA (p.Arg269fs)	VPS13C	R226fs, R269fs	Parkinson disease	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222068	15	62305256 - 62305257	15	62013057 - 62013058	222068	223769	rs879253853	NC_000015.10:62013057::TCTG
NM_018206.6(VPS35):c.*259_*260dup	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319287	16	46694123 - 46694124	16	46660211 - 46660212	319287	335039	rs886052011	NC_000016.10:46660211:TA:TATA
NM_018206.6(VPS35):c.*275_*276insCAA	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319286	16	46694108 - 46694109	16	46660196 - 46660197	319286	343006	rs886052010	NC_000016.10:46660196:TT:TTGTT
NM_018206.6(VPS35):c.*276_*277insCAA	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319284	16	46694107 - 46694108	16	46660195 - 46660196	319284	341499	rs886052008	NC_000016.10:46660195:TT:TTGTT
NM_018206.6(VPS35):c.*277_*278insCA	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319283	16	46694106 - 46694107	16	46660194 - 46660195	319283	325358	rs886052007	NC_000016.10:46660194:T:TGT
NM_018206.6(VPS35):c.*278_*279insCAA	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319282	16	46694105 - 46694106	16	46660193 - 46660194	319282	343005	rs575317929	NC_000016.10:46660193:TT:TTGTT
NM_018206.6(VPS35):c.*279_*280insCAAA	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319281	16	46694104 - 46694105	16	46660192 - 46660193	319281	343001	rs886052006	NC_000016.10:46660192:TTT:TTTGTTT
NM_018206.6(VPS35):c.*281delinsAAAAA	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319280	16	46694103	16	46660191	319280	325355	rs1555522775	NC_000016.10:46660190:G:TTTTT
NM_018206.6(VPS35):c.*281delinsAAAA	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319279	16	46694103	16	46660191	319279	342998	rs1555522775	NC_000016.10:46660190:G:TTTT
NM_018206.6(VPS35):c.*285_*287dup	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319276	16	46694096 - 46694097	16	46660184 - 46660185	319276	342992	rs369068093	NC_000016.10:46660184:TTTT:TTTTTTT
NM_018206.6(VPS35):c.*287dup	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319275	16	46694096 - 46694097	16	46660184 - 46660185	319275	342995	rs369068093	NC_000016.10:46660184:TTTT:TTTTT
NM_018206.6(VPS35):c.*287_*288insAAAC	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319274	16	46694096 - 46694097	16	46660184 - 46660185	319274	335036	rs1555522760	NC_000016.10:46660184::GTTT
NM_018206.6(VPS35):c.*287_*288insAAC	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319273	16	46694096 - 46694097	16	46660184 - 46660185	319273	342991	rs1555522760	NC_000016.10:46660184::GTT
NM_018206.6(VPS35):c.*761_*762dup	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319267	16	46693621 - 46693622	16	46659709 - 46659710	319267	335034	rs34926621	NC_000016.10:46659709:AAAAAAAAAAA:AAAAAAAAAAAAA
NM_018206.6(VPS35):c.*762dup	VPS35		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319266	16	46693621 - 46693622	16	46659709 - 46659710	319266	341491	rs34926621	NC_000016.10:46659709:AAAAAAAAAAA:AAAAAAAAAAAA
